Robert Lafyatis

The state of differentiation of HT‐29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator

G. Huet, R. Lafyatis, B. Hémon, 1994, International journal of cancer.

THU0329 SAFETY, TARGET ENGAGEMENT, AND INITIAL EFFICACY OF AVID200, A FIRST-IN-CLASS POTENT AND ISOFORM-SELECTIVE INHIBITOR OF TGF-BETA 1 AND 3, IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): A PHASE 1 DOSE ESCALATION STUDY

A. Papazoglou, R. Domsic, R. Lafyatis, 2020 .